Found 12 results
Author Title Type [ Year
] Filters: Author is Edupuganti, Srilatha [Clear All Filters]
. 2020. “Baseline Levels Of Influenza-Specific B Cells And T Cell Responses Modulate Human Immune Responses To Swine Variant Influenza A/h3N2 Vaccine.”. Vaccines (Basel) 8 (1). Vaccines (Basel). doi:10.3390/vaccines8010126.
. 2020. “Duration Of Cellular And Humoral Responses After Quadrivalent Human Papillomavirus Vaccination In Healthy Female Adults With Or Without Prior Type 16 And/or 18 Exposure.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030348.
. 2019. “Clinical, Virologic, And Immunologic Characteristics Of Zika Virus Infection In A Cohort Of Us Patients: Prolonged Rna Detection In Whole Blood.”. Open Forum Infect Dis 6 (1). Open Forum Infect Dis: ofy352. doi:10.1093/ofid/ofy352.
. 2017. “Tularemia Vaccine: Safety, Reactogenicity, "take" Skin Reactions, And Antibody Responses Following Vaccination With A New Lot Of The Francisella Tularensis Live Vaccine Strain - A Phase 2 Randomized Clinical Trial.”. Vaccine 35 (36). Vaccine: 4730-4737. doi:10.1016/j.vaccine.2017.07.024.
. 2015. “Comparison Of Lyophilized Versus Liquid Modified Vaccinia Ankara (Mva) Formulations And Subcutaneous Versus Intradermal Routes Of Administration In Healthy Vaccinia-Naïve Subjects.”. Vaccine 33 (39). Vaccine: 5225-34. doi:10.1016/j.vaccine.2015.06.075.
. 2015. “Dna Priming For Seasonal Influenza Vaccine: A Phase 1B Double-Blind Randomized Clinical Trial.”. Plos One 10 (5). Plos One: e0125914. doi:10.1371/journal.pone.0125914.
. 2015. “Phase Ii Trial In Adults Of Concurrent Or Sequential 2009 Pandemic H1N1 And 2009-2010 Seasonal Trivalent Influenza Vaccinations.”. Vaccine 33 (1). Vaccine: 163-73. doi:10.1016/j.vaccine.2014.10.083.
. 2015. “Safety And Immunogenicity Of A Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine In Healthy Persons ≥18 Years Old.”. J Infect Dis 212 (4). J Infect Dis: 552-61. doi:10.1093/infdis/jiv056.
. 2014. “Immunogenicity Of Avian Influenza A/anhui/01/2005(H5N1) Vaccine With Mf59 Adjuvant: A Randomized Clinical Trial.”. Jama 312 (14). Jama: 1420-8. doi:10.1001/jama.2014.12609.
. 2014. “Serological Responses To An Avian Influenza A/h7N9 Vaccine Mixed At The Point-Of-Use With Mf59 Adjuvant: A Randomized Clinical Trial.”. Jama 312 (14). Jama: 1409-19. doi:10.1001/jama.2014.12854.
. 2012. “Immunogenicity And Safety Of Varying Dosages Of A Monovalent 2009 H1N1 Influenza Vaccine Given With And Without As03 Adjuvant System In Healthy Adults And Older Persons.”. J Infect Dis 206 (6). J Infect Dis: 811-20. doi:10.1093/infdis/jis427.
. 2011. “Safety And Immunogenicity Of Influenza A H5 Subunit Vaccines: Effect Of Vaccine Schedule And Antigenic Variant.”. J Infect Dis 203 (5). J Infect Dis: 666-73. doi:10.1093/infdis/jiq093.